Toxicological evaluation and metabolism of two N-alkyl benzamide umami flavour compounds: N-(heptan-4-yl)benzo[d][1,3]dioxole-5-carboxamide and (R)-N-(1-methoxy-4-methylpentan-2-yl)-3,4-dimethylbenzamide.

Physiological parameters in laboratory animals and humans. Pharm Res (1993) 8.14

Human receptors for sweet and umami taste. Proc Natl Acad Sci U S A (2002) 5.91

Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry (1995) 4.10

Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev (1999) 3.81

Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. Toxicol Pathol (2010) 2.09

Molecular mechanism for the umami taste synergism. Proc Natl Acad Sci U S A (2008) 1.53

Sex-dependent metabolism of xenobiotics. Drug Metab Rev (1998) 1.24

Importance of demethylenation in the metabolism in vivo and in vitro of methylenedioxyphenyl synergists and related compounds in mammals. Biochem Pharmacol (1970) 1.16

Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. Toxicol Lett (1992) 1.10

T1R receptors mediate mammalian sweet and umami taste. Am J Clin Nutr (2009) 1.10

Review of the regulation and safety assessment of food substances in various countries and jurisdictions. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2013) 1.05

Under the conditions of intended use - New developments in the FEMA GRAS program and the safety assessment of flavor ingredients. Food Chem Toxicol (2008) 1.03

Catechol O-methyltransferase. IV. Factors affecting m- and p-methylation of substituted catechols. Mol Pharmacol (1972) 1.00

Catechol O-methyltransferase. 3. M- and p-O-methylation of catecholamines and their metabolites. Mol Pharmacol (1970) 0.87

Role of catechol-O-methyltransferase in the disposition of luteolin in rats. Drug Metab Dispos (2011) 0.84

Molecular modeling and metabolic studies of the interaction of catechol-O-methyltransferase and a new nitrocatechol inhibitor. Drug Metab Dispos (2003) 0.83

Metabolism of piperonal and piperonyl alcohol in the rat with special reference to the scission of the methylenedioxy group. Acta Pharm Suec (1984) 0.81

Toxicological evaluation of the flavour ingredient N-(1-((4-amino-2,2-dioxido-1H-benzo[c][1,2,6]thiadiazin-5-yl)oxy)-2-methylpropan-2-yl)-2,6-dimethylisonicotinamide (S2218). Toxicol Rep (2017) 0.75

Toxicological evaluation of the flavour ingredient 4-amino-5-(3-(isopropylamino)-2,2-dimethyl-3-oxopropoxy)-2-methylquinoline-3-carboxylic acid. Toxicol Rep (2015) 0.75

Toxicological evaluation of a novel umami flavour compound: 2-(((3-(2,3-Dimethoxyphenyl)-1H-1,2,4-triazol-5-yl)thio)methyl)pyridine. Toxicol Rep (2016) 0.75

Toxicological evaluation of two novel bitter modifying flavour compounds: 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1H-pyrazol-4-yl)-1-(3-hydroxybenzyl)imidazolidine-2,4-dione and 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1H-pyrazol-4-yl)-1-(3-hydroxybenzyl)-5,5-dimethylimidazolidine-2,4-dione. Toxicol Rep (2016) 0.75